M1 macrophages, activated through the classical pathway by interferon-gamma (IFN-γ), are typically present in the tumor microenvironment (TME) during early stages of acute inflammation, promoting an anti-tumoral inflammatory response [17,66]. This evidence concerns the gene IFNG and neoplasm.